ArticleHealth science reports2026

RSV Monoclonal Antibody Implementation for At-Risk Infants: Victoria, Australia's 2024 Experience.

Jane Tuckerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.